Secondary Logo

Institutional members access full text with Ovid®

Share this article on:

Behavioral Changes in Huntington Disease

Craufurd, David*; Thompson, Jennifer C.*†; Snowden, Julie S.

Neuropsychiatry, Neuropsychology & Behavioral Neurology: October-December 2001 - Volume 14 - Issue 4 - p 219-226
Original Articles

Objectives This study aimed to gain a better understanding of behavioral abnormalities in Huntington disease (HD) and to develop a method for reliably assessing these changes.

Background Behavioral changes are a central feature of HD and often cause considerable distress and difficulty to patients and their relatives. However, they have received little attention from research despite their prevalence and clinical significance.

Methods One hundred thirty-four patients with HD were assessed using the Problem Behaviors Assessment for Huntington Disease (PBA-HD), an instrument for rating the presence, severity and frequency of behavioral abnormalities in HD.

Results The findings confirm that behavioral problems are common among patients with HD. The most common symptoms were loss of energy and initiative, poor perseverance and quality of work, impaired judgment, poor self-care and emotional blunting. Affective symptoms such as depression, anxiety and irritability occurred in around half the patients studied. Psychotic symptoms (hallucinations and delusions) were rarely reported. Factor analysis distinguished three clusters of behavioral symptoms, which were interpreted respectively as reflecting Apathy, Depression and Irritability. The `Apathy' factor was highly correlated with duration of illness, whereas no such relationship was observed for the `Depression' and `Irritability' factors.

Conclusions The results suggest that certain behavioral changes are fundamental to the progression of HD, whereas others have a more complex relationship to the disease process. The findings have implications for the choice of behavioral measures used to evaluate efficacy of therapeutic interventions.

*Academic Unit of Medical Genetics and Regional Genetic Service, St Mary's Hospital and †Greater Manchester Neurosciences Centre, Hope Hospital, Manchester, UK.

Received November 13, 2000;

revised April 24, 2001; accepted June 12, 2001.

Address correspondence and reprint requests to Dr. David Craufurd, Department of Medical Genetics, St Mary's Hospital, Manchester M13 0JH, UK; email: david.craufurd@man.ac.uk

© 2001 Lippincott Williams & Wilkins, Inc.